{"lastModified":"2024-02-09T22:00:16","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=1191","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=CZYFVQ","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/1191/body","rel":"body"}],"num":1191,"receiptDate":"2024-01-26","term":10,"title":"Interpelacja w sprawie objęcia refundacją w ramach programów lekowych dotyczących wrzodziejącego zapalenia jelita grubego i choroby Leśniowskiego-Crohna terapii lekiem upadacytynib, tzn. lekiem immunomodulującym z grupy inhibitorów kinaz janusowych","answerDelayedDays":0,"from":["170","425","426"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2024-01-30"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTD2AJXR/i01191-o1.pdf","lastModified":"2024-02-09T22:00:16","name":"i01191-o1.pdf"}],"from":"Podsekretarz stanu Maciej Miłkowski","key":"D2AJXR","lastModified":"2024-02-09T22:00:16","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=D2AJXR","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/1191/reply/D2AJXR/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2024-02-08"}],"sentDate":"2024-01-30","to":["minister zdrowia"]}